Copeland Capital Management, LLC Pfizer Inc Transaction History

Copeland Capital Management, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 12, 2022	SELL	$43.76 - $53.42 $14,659 - $17,895	-335 Reduced 6.3%	4,983 $218,000
Q1 2021 Jan 18, 2022	BUY	$33.49 - $37.77 $178,099 - $200,860	5,318 New	5,318 $193,000
Q1 2021 Apr 26, 2021	SELL	$33.49 - $37.77 $178,099 - $200,860	-5,318 Closed	0 $0
Q4 2020 Jan 18, 2022	BUY	$33.47 - $42.56 $177,993 - $226,334	5,318 New	5,318 $196,000
Q4 2020 Jan 27, 2021	SELL	$33.47 - $42.56 $177,993 - $226,334	-5,318 Closed	0 $0
Q3 2020 Jan 18, 2022	BUY	$31.75 - $37.25 $168,846 - $198,095	5,318 New	5,318 $195,000
Q3 2020 Oct 22, 2020	SELL	$31.75 - $37.25 $168,846 - $198,095	-5,318 Closed	0 $0
Q2 2020 Jan 18, 2022	BUY	$30.12 - $36.54 $160,178 - $194,319	5,318 New	5,318 $174,000
Q2 2020 Jul 30, 2020	SELL	$30.12 - $36.54 $160,178 - $194,319	-5,318 Closed	0 $0
Q1 2020 Jan 18, 2022	BUY	$27.03 - $38.62 $143,745 - $205,381	5,318 New	5,318 $174,000
Q1 2020 Apr 29, 2020	SELL	$27.03 - $38.62 $143,745 - $205,381	-5,318 Closed	0 $0
Q3 2019 Jan 18, 2022	BUY	$32.49 - $42.13 $172,781 - $224,047	5,318 New	5,318 $191,000
Q3 2019 Nov 06, 2019	SELL	$32.49 - $42.13 $172,781 - $224,047	-5,318 Closed	0 $0
Q1 2019 Apr 24, 2019	SELL	$37.5 - $41.2 $96,712 - $106,254	-2,579 Reduced 32.66%	5,318 $226,000
Q4 2018 Jan 28, 2019	SELL	$38.47 - $43.86 $1,615 - $1,842	-42 Reduced 0.53%	7,897 $345,000
Q4 2017 Jan 30, 2018	BUY	$33.26 - $35.29 $1,396 - $1,482	42 Added 0.53%	7,939 $288,000
Q3 2017 Oct 27, 2017	BUY	$31.0 - $34.15 $244,807 - $269,682	7,897	7,897 $282,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Copeland Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Copeland Capital Management, LLC with notifications on news.